At a recent meeting in Boston, representatives from global pharmaceutical companies gathered to discuss how to transition from batch to continuous manufacturing. And what company better to learn from ...
Laine Mello, director of Marketing at Ecolab for its bioprocessing business, shares her insights on the digital ...
Transform the production of oral solid dosage forms in the pharmaceutical industry with L.B. Bohle. L.B. Bohle supports companies with their machines and processes in adopting Continuous Manufacturing ...
Continuous Biologics Manufacturing for Modular and Sustainable Operations, Upcoming Webinar Hosted by Xtalks ...
A handful of companies have done pioneering work with continuous manufacturing, the production process that is faster, cheaper and less prone to the kinds of manufacturing mess-ups that worry the FDA.
Although estimates vary slightly, many industry experts predict continuous manufacturing will, at the least, cut the cost of manufacturing biologics in half. Thus, it will be an attractive option for ...
The main market opportunities lie in enhancing supply chain resilience, reducing production costs and cycle times, and supporting environmental sustainability. The integration of continuous ...
The biopharmaceutical industry has seen substantial growth in recent years, generating novel biotherapeutics and biosimilars at an unprecedented rate. One of the biggest challenges in the industry is ...
Continuous manufacturing makes monoclonal antibody production faster, cheaper, and greener, say researchers, who predict that industry adoption of the approach will accelerate in response to ...
Continued process verification (CPV) is the third stage of the product lifecycle of any medicine either within the small or large molecule arena. The CPV is the subsequent step to process design ...
DIANT is a startup co-founded by Antonio Costa, Ph.D. and Diane Burgess, Ph.D. In 2020, DIANT licensed their core manufacturing technology from UConn and was granted a patent on the technology earlier ...